Table 2.
Lung organoids derived from different cell sources
| Cell Sources | Types of Lung Organoids | References | |
|---|---|---|---|
| PSCs | induced PSCs | airway and alveolar structures | [53] |
| alveolar organoids | [54] | ||
| alveolar organoids | [55] | ||
| airway organoids | [56] | ||
| airway and alveolar organoids | [57] | ||
| embryonic stem cells | airway spheroids | [58] | |
| lung organoids | [59] | ||
| patient-derived samples | tumor tissue of primary lung cancer patients and patient-derived xenograft | NSCLC organoids | [60] |
| patient-derived tissues | LADC organoids | [61] | |
| fragments tumor tissues | LCOs | [62] | |
| nasal brushing samples of PCD patients | COPD bronchial organoids | [63] | |
| MSE samples | LCOs | [64] | |
| normal samples | bronchial epithelial cells, fibroblasts, and microvascular endothelial cells | airway organoids | [65] |
| primary lung tissues | alveolar organoids | [66] | |
| airway and alveolar organoids | [67] | ||
PSCs: pluripotent stem cells; NSCLC: non-small cell lung cancer; LADC: lung adenocarcinoma; LCOs: lung cancer organoids; PCD: primary ciliary dyskinesia; COPD: chronic obstructive pulmonary disease; MSE: malignant serous effusion